| n = 36 |
Age (year) | 50.8 ± 19.0 |
Age range (year) | 19 - 82 |
Diagnosis age (year) | 43.4 ± 17.2 |
Sex |
|
Male | 25 (69.4%) |
Female | 11 (30.6%) |
Diagnosis length (year) | 6 (1 - 20) |
Family history | 29 (80.5%) |
Accompanying disease |
|
HT | 27 (75.0%) |
CKD | 21 (58.3) |
Liver Cyst | 23 (63.9%) |
Intracranial aneurysm | 1 (%2.8) |
Valve disease | 6 (16.7%) |
CAH | 5 (13.9%) |
LVH | 18 (50%) |
DM | 5 (13.9%) |
Nephrolithiasis | 8 (22.2%) |
Macroscopic hematuria | 6 (16.7%) |
Proteinuria | 11 (30.6%) |
CKD length (year) | 6 (3 - 15) |
Hemodialysis | 7 (19.4%) |
Renal transplantation | 3 (8.3%) |
Antihypertensive medication used |
|
ARB | 9 (25%) |
ACE-I | 8 (22.2%) |
ARB + Calcium channel blocker | 4 (11.1%) |
ARB + Beta blocker | 2 (5.6%) |
ACE-I + Calcium Channel blocker | 3 (8.3%) |
ACE-I + Beta blocker | 1 (2.8%) |
None | 9 (25.0%) |